IBI356 is a humanized monoclonal antibody inhibitor that targets OX40L/CD134L/CD252. It can be utilized in the study of chronic inflammatory skin diseases, such as atopic dermatitis.
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted
